Market Place
Sourcing Support
Enforcement Report- Week of October 27, 2021
27 Oct 2021 //
FDA
Enforcement Report - Week of May 8, 2019
08 May 2019 //
FDA
Enforcement Report - Week of October 17, 2018
17 Oct 2018 //
FDA
Gattex (teduglutide), Amlodipine and Valsartan Tabs : Shire-NPS Pharm v. Par Pharma et al.
30 Jul 2018 //
PATENT LITIGATION
Zydus Pharms USA Inc.`s Generic Glipizide Receives Approval In The US
21 Jul 2018 //
FDA
Zydus Cadila gets USFDA nod to market 4 generic products
17 Jul 2018 //
HINDU BUSINESS LINE
Aurobindo Pharma’s Generic Glipizide Receives Approval In US
12 May 2017 //
Enforcement Report - Week of March 22, 2017
22 Mar 2017 //
FDA
Mylan extends recall as stray tablets of diabetes med show up in bottles
16 Mar 2017 //
FIERCE PHARMA
Enforcement Report - Week of March 8, 2017
08 Mar 2017 //
FDA
Enforcement Report - Week of March 1, 2017
01 Mar 2017 //
FDA
Enforcement Report - Week of February 22, 2017
22 Feb 2017 //
FDA
Teva recalls 500,000 units of diabetes drug manufactured by Patheon
17 Feb 2017 //
FIERCE PHARMA
Unique`s Generic Glipizide Receives Approval In US
29 Dec 2016 //
FDA
Formulation development of Glipizide matrix tablet
10 Nov 2016 //
PHARMA EXCIPIENTS
DOJ`s price-fixing investigation could lead to sizable liabilities, analyst says
10 Nov 2016 //
FIERCE PHARMA
Endo`s Par recalls half a million birth control pills made by Patheon
02 Nov 2016 //
FIERCE PHARMA
Controlled release matrix tablets of glipizide
09 May 2016 //
PHARMA-EXCIPIENTS
Mylan`s Generic Glipizide (2.5, 5, 10 Mg) Approved in US For Diabetes
22 May 2015 //
FDA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.